Category: Pharmaceuticals - Page 2

Opioid-induced nausea affects up to one-third of patients and often leads to treatment failure. Learn which antiemetics actually work, when to avoid them, and how to manage nausea safely without unnecessary drugs.

Insurers use preferred generic lists to cut drug costs, but these formularies can limit your choices and surprise you at the pharmacy. Learn how tiers work, why generics are pushed, and what you can do to save money and fight denials.

SSRI antidepressants are safe alone but dangerous when mixed with other serotonergic drugs. Learn which medications, opioids, and supplements raise serotonin syndrome risk - and how to prevent a life-threatening reaction.

African-made antiretroviral generics are transforming HIV treatment access, reducing dependency on imports and improving supply reliability. With WHO-prequalified drugs like TLD now produced locally, the continent is building health sovereignty and saving lives.

Biologic DMARDs have transformed rheumatoid arthritis treatment, offering real remission for many patients. Learn how these targeted therapies work, which ones are most effective, and what to expect in terms of results, side effects, and costs.

Generic drug user fees fund the FDA's review process, speeding up access to affordable medications. Learn how GDUFA works, who pays, and why it matters for patients and manufacturers.

Digoxin and amiodarone together can cause deadly toxicity due to a well-documented drug interaction. Learn why dose reduction is mandatory, how to monitor safely, and what alternatives exist.

The FDA uses priority and standard review paths for generic drugs. Priority review speeds up approval by two months for first generics, shortage drugs, and U.S.-made products. Learn how the system works and why it matters.

Opioid-induced constipation affects 40-60% of patients on long-term opioids and doesn't go away on its own. Learn how to prevent it with early laxative use and when to turn to PAMORAs like naldemedine for effective relief.

Beta-blockers can trigger or worsen psoriasis in up to 20% of users, with metoprolol and propranolol being the most common culprits. Learn how to spot the connection and what to do next.